[
  {
    "objectID": "Tables/T3T4T5.html",
    "href": "Tables/T3T4T5.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Table 3\n\n Download Table S3 (CSV) \n\nSupplementary Table 3: Differential abundance of species across CSTs.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = abundance +(1|PATIENTID) model = LMCLR\n\n\n\n\nSupplementary Table 4\n\n Download Table S4 (CSV) \n\n\nSupplementary Table 4: Differential abundance of Antibiotic Resistance Genes (ARGs) across CSTs.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = abundance +(1|PATIENTID) model = CPLM\n\n\n\n\nSupplementary Table 5\n\n Download Table S5 (CSV) \n\n\nSupplementary Table 5: Differential abundance of Mobile Genetic Elements (MGEs) across CSTs.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = abundance +(1|PATIENTID)  model = CPLM"
  },
  {
    "objectID": "Tables/T1T8T9.html",
    "href": "Tables/T1T8T9.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Table 1\n\n Download Table S1 (CSV) \n\nSupplementary Table 1 : Descriptive statistics of patients involved in the InSPIRe study\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nSD: Standard Deviation ; NA: Not availaible\n\n\n\n\nSupplementary Table 8\n\n Download Table S8 (CSV) \n\n\nSupplementary Table 8: Comparison of clinical characteristics across pregnancy outcome groups (A-D).\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nCategorical variables were tested using the chi-square statistical test. In cases where expected counts were &lt; 5, groups A and B and groups C and D were grouped. Continuous variables were assessed using the Kruskal-Wallis statistical test. Multiple-testing correction was performed using the Benjamini-Hochberg FDR procedure. A: Full Term (Control); B: Full Term Early Membrane Rupture (PROM); (C) Preterm Labor (PTL); (D) Premature Early Membrane Rupture (PPROM).\n\n\n\n\nSupplementary Table 9\n\n Download Table S9 (CSV) \n\n\nSupplementary Table 9: Detailed antibiotic molecules consumed during pregnancy.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)"
  },
  {
    "objectID": "Reports/R9R10.html",
    "href": "Reports/R9R10.html",
    "title": "\nα-diversity comparison across CSTs (External Dataset - ENA Number: PRJEB34536)\n",
    "section": "",
    "text": "Significance codes: *** p &lt; 0.001, ** p &lt; 0.01, * p &lt; 0.05, . p &lt; 0.1\n\n\nα-diversity comparison across CSTs (External Dataset - ENA Number: PRJEB34536)\n\n\n\nReport 9\n\n\nReport 9: Comparison of ARG α-diversity metrics across vaginal community state types (CST) in an independent external cohort of pregnant women (PRJEB34536).\n\n\n\nAntibiotic Resistance Genes (ARG)\n\n\n\nData: Shannon by CST\n\n\nKruskal-Wallis chi-squared = 15.366, df = 4, p-value = 0.003998 Pairwise comparisons using Wilcoxon rank sum test with continuity correction p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n0.2016\n\n\n-\n\n\n-\n\n\n-\n\n\n\n\nCST III\n\n\n0.0038 (**)\n\n\n0.2016\n\n\n-\n\n\n-\n\n\n\n\nCST IV\n\n\n0.0080 (**)\n\n\n0.3409\n\n\n0.5510\n\n\n-\n\n\n\n\nCST V\n\n\n0.2016\n\n\n0.9341\n\n\n0.2016\n\n\n0.3464\n\n\n\n\n\nData: Phenotypic Resistance Diversity Index (PRDI) by CST\n\n\nKruskal-Wallis chi-squared = 40.536, df = 4, p-value = 3.352e-08 Pairwise comparisons using Wilcoxon rank sum test with continuity correction p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n0.1845\n\n\n-\n\n\n-\n\n\n-\n\n\n\n\nCST III\n\n\n1.4e-06 (***)\n\n\n0.0028 (**)\n\n\n-\n\n\n-\n\n\n\n\nCST IV\n\n\n1.1e-05 (***)\n\n\n0.0079 (**)\n\n\n0.9621\n\n\n-\n\n\n\n\nCST V\n\n\n0.5881\n\n\n0.7065\n\n\n0.0048 (**)\n\n\n0.0096 (**)\n\n\n\n\n\n\n\nReport 10\n\n\nReport 10: Association between vaginal community state Type (CST) and gene detection in an independent external cohort of pregnant women (PRJEB34536).\n\n\nPearson’s Chi-squared test with Yates’ continuity correction Chi-squared = 39.785, df = 1, p-value = 2.836e-10 (***) P value adjustment method: BH\n\n\n\n\n\n\n\n\n\n\n\nCST III/IV\n\n\n\n\n\n\nCST I/II/V\n\n\n9.8e-11\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbsence\n\n\nPresence\n\n\n\n\n\n\nCST I/II/V\n\n\n54\n\n\n5\n\n\n\n\nCST III/V\n\n\n7\n\n\n23"
  },
  {
    "objectID": "Reports/R6R7.html",
    "href": "Reports/R6R7.html",
    "title": "VagResist",
    "section": "",
    "text": "Significance codes: *** p &lt; 0.001, ** p &lt; 0.01, * p &lt; 0.05, . p &lt; 0.1\n\n\n\nReport 6\n\n\nReport 6: Multivariate Log-transformed Gaussian mixed-effects models of species α-diversity across pregnancy outcome groups (A-D).\n\n\n\nModel estimates\n\n\n\nFamily: gaussian Formula: diversity_metric ~ pregnancy outcome group (A-D) + antibiotic treatment during pregnancy + maternal age + body mass index (BMI) + cervical cerclage + intrauterine growth restriction (IUGR) + gestational diabetes + hypertensive disorders of pregnancy + (1 | patient)\n\n\nData: Shannon by pregnancy outcome groups (A-D) Number of observations: 1943; groups: PATIENT, 1533 Dispersion estimate for gaussian family (sigma^2): 0.136\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\nPr(&gt;|z|)\n\n\n\n\n\n\n(Intercept)\n\n\n0.675190\n\n\n0.094448\n\n\n7.149\n\n\n8.76e-13(***)\n\n\n\n\nGroup B\n\n\n-0.048367\n\n\n0.034064\n\n\n-1.420\n\n\n0.155646\n\n\n\n\nGroup C\n\n\n-0.003915\n\n\n0.030601\n\n\n-0.128\n\n\n0.898197\n\n\n\n\nGroup D\n\n\n0.131271\n\n\n0.033168\n\n\n3.958\n\n\n7.56e-05(***)\n\n\n\n\nAntibiotic (Yes)\n\n\n0.053282\n\n\n0.025680\n\n\n2.075\n\n\n0.038000(*)\n\n\n\n\nMaternal age\n\n\n-0.002158\n\n\n0.002276\n\n\n-0.948\n\n\n0.343089\n\n\n\n\nBMI\n\n\n0.008488\n\n\n0.002242\n\n\n3.786\n\n\n0.000153(***)\n\n\n\n\nCervical cerclage (Yes)\n\n\n0.158989\n\n\n0.048500\n\n\n3.278\n\n\n0.001045(**)\n\n\n\n\nIUGR (Yes)\n\n\n-0.006759\n\n\n0.047632\n\n\n-0.142\n\n\n0.887162\n\n\n\n\nGestational diabetes (Yes)\n\n\n-0.003931\n\n\n0.030063\n\n\n-0.131\n\n\n0.895973\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.034643\n\n\n0.067685\n\n\n0.512\n\n\n0.608772\n\n\n\n\n\nConfidence level: 0.95 Results are averaged over the levels of antibiotic treatment during pregnancy; maternal age; BMI; cervical cerclage; IUGR; gestational diabetes; hypertensive disorders. p-value adjustment: Tukey method for comparing a family of 4 estimates\n\n\n\n\n\n\n\n\n\n\n\n\n\ncontrast\n\n\nestimate\n\n\nSE\n\n\ndf\n\n\nt.ratio\n\n\np.value\n\n\n\n\n\n\nA vs B\n\n\n0.04836675\n\n\n0.03406423\n\n\n1930\n\n\n1.420\n\n\n0.4870\n\n\n\n\nA vs C\n\n\n0.00391503\n\n\n0.03060054\n\n\n1930\n\n\n0.128\n\n\n0.9993\n\n\n\n\nA vs D\n\n\n-0.13127106\n\n\n0.03316786\n\n\n1930\n\n\n-3.958\n\n\n0.0005 (***)\n\n\n\n\nB vs C\n\n\n-0.04445172\n\n\n0.03570120\n\n\n1930\n\n\n-1.245\n\n\n0.5981\n\n\n\n\nB vs D\n\n\n-0.17963781\n\n\n0.03398566\n\n\n1930\n\n\n-5.286\n\n\n&lt;.0001 (***)\n\n\n\n\nC vs D\n\n\n-0.13518609\n\n\n0.03444635\n\n\n1930\n\n\n-3.925\n\n\n0.0005 (***)\n\n\n\n\n\nData: Phylogenetic Diversity (PD) by pregnancy outcome groups (A-D) Family: gaussian Number of observations: 1943; groups: PATIENT, 1533 Dispersion estimate for gaussian family (sigma^2): 0.178\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\nPr(&gt;|z|)\n\n\n\n\n\n\n(Intercept)\n\n\n3.483004\n\n\n0.102402\n\n\n34.01\n\n\n&lt; 2e-16 (***)\n\n\n\n\nGroup B\n\n\n0.087636\n\n\n0.037105\n\n\n2.36\n\n\n0.018185 (*)\n\n\n\n\nGroup C\n\n\n0.134720\n\n\n0.033408\n\n\n4.03\n\n\n5.52e-05 (***)\n\n\n\n\nGroup D\n\n\n0.234469\n\n\n0.036157\n\n\n6.48\n\n\n8.89e-11 (***)\n\n\n\n\nAntibiotic (Yes)\n\n\n-0.063485\n\n\n0.027868\n\n\n-2.28\n\n\n0.022723 (*)\n\n\n\n\nMaternal age\n\n\n-0.008379\n\n\n0.002467\n\n\n-3.40\n\n\n0.000682 (***)\n\n\n\n\nBMI\n\n\n0.015266\n\n\n0.002430\n\n\n6.28\n\n\n3.32e-10 (***)\n\n\n\n\nCervical cerclage (Yes)\n\n\n0.081353\n\n\n0.052493\n\n\n1.55\n\n\n0.121193\n\n\n\n\nIUGR (Yes)\n\n\n0.021445\n\n\n0.051594\n\n\n0.42\n\n\n0.677659\n\n\n\n\nGestational diabetes (Yes)\n\n\n0.005456\n\n\n0.032629\n\n\n0.17\n\n\n0.867201\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.120878\n\n\n0.073219\n\n\n1.65\n\n\n0.098756\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\n\ncontrast\n\n\nestimate\n\n\nSE\n\n\ndf\n\n\nt.ratio\n\n\np.value\n\n\n\n\n\n\nA vs B\n\n\n-0.08763583\n\n\n0.03710515\n\n\n1930\n\n\n-2.362\n\n\n0.0849 (.)\n\n\n\n\nA vs C\n\n\n-0.13472018\n\n\n0.03340774\n\n\n1930\n\n\n-4.033\n\n\n0.0003 (***)\n\n\n\n\nA vs D\n\n\n-0.23446873\n\n\n0.03615738\n\n\n1930\n\n\n-6.485\n\n\n&lt;.0001 (***)\n\n\n\n\nB vs C\n\n\n-0.04708435\n\n\n0.03881563\n\n\n1930\n\n\n-1.213\n\n\n0.6186\n\n\n\n\nB vs D\n\n\n-0.14683290\n\n\n0.03696010\n\n\n1930\n\n\n-3.973\n\n\n0.0004 (***)\n\n\n\n\nC vs D\n\n\n-0.09974855\n\n\n0.03731957\n\n\n1930\n\n\n-2.673\n\n\n\n\n\n\n\n\n\n\n\n\n\nReport 7\n\n\nReport 7: Multivariate Hurdle mixed-effects models (binomial and log-transformed Gaussian) assessing ARG and MGE detection and diversity across pregnancy outcome groups (A-D).\n\n\nModel estimates\n\n\nFormula: diversity_metric ~ outcome_group + antibiotic treatment + maternal age + body mass index (BMI) + cervical cerclage + intrauterine growth restriction (IUGR) + gestational diabetes + hypertensive disorders of pregnancy + (1 | patient)\n\n\n\n Antibiotic Resistance Genes (ARG)\n\n\n\nData: Shannon by pregnancy outcome groups (A-D) Part I. Family: binomial Number of observations: 1943, groups: PATIENT, 1533\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nIntercept\n\n\n-0.348\n\n\n0.483\n\n\n-0.72\n\n\n0.471\n\n\n\n\nGroup B vs A\n\n\n-0.015\n\n\n0.174\n\n\n-0.08\n\n\n0.933\n\n\n\n\nGroup C vs A\n\n\n0.483\n\n\n0.157\n\n\n3.07\n\n\n0.002 (**)\n\n\n\n\nGroup D vs A\n\n\n0.034\n\n\n0.168\n\n\n0.20\n\n\n0.838\n\n\n\n\nAntibiotic (Yes)\n\n\n0.239\n\n\n0.132\n\n\n1.81\n\n\n0.070 (.)\n\n\n\n\nMaternal age\n\n\n-0.035\n\n\n0.012\n\n\n-2.97\n\n\n0.003 (**)\n\n\n\n\nBMI\n\n\n0.061\n\n\n0.012\n\n\n5.04\n\n\n&lt; 1e-6 (***)\n\n\n\n\nCervical cerclage (Yes)\n\n\n0.713\n\n\n0.264\n\n\n2.70\n\n\n0.007 (**)\n\n\n\n\nIUGR (Yes)\n\n\n-0.024\n\n\n0.244\n\n\n-0.10\n\n\n0.923\n\n\n\n\nGestational diabetes (Yes)\n\n\n0.139\n\n\n0.154\n\n\n0.91\n\n\n0.364\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.469\n\n\n0.359\n\n\n1.31\n\n\n0.191\n\n\n\n\n\nEstimated marginal probability on the response scale Results are averaged over the levels of antibiotic treatment during pregnancy; maternal age; BMI; cervical cerclage; IUGR; gestational diabetes; hypertensive disorders. Confidence level: 0.95\n\n\n\n\n\n\n\n\n\n\n\n\nOUT_GROUP\n\n\nProbability\n\n\nSE\n\n\n95% CI (Lower)\n\n\n95% CI (Upper)\n\n\n\n\n\n\nA\n\n\n0.684\n\n\n0.058\n\n\n0.561\n\n\n0.785\n\n\n\n\nB\n\n\n0.681\n\n\n0.062\n\n\n0.550\n\n\n0.788\n\n\n\n\nC\n\n\n0.778\n\n\n0.045\n\n\n0.677\n\n\n0.854\n\n\n\n\nD\n\n\n0.691\n\n\n0.057\n\n\n0.571\n\n\n0.790\n\n\n\n\n\nPairwise comparisons were adjusted using Tukey’s method Confidence level: 0.95\n\n\n\n\n\n\n\n\n\n\n\n\nContrast (OUT_GROUP)\n\n\nOdds ratio\n\n\nSE\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n1.015\n\n\n0.176\n\n\n0.08\n\n\n0.9998\n\n\n\n\nA vs C\n\n\n0.617\n\n\n0.097\n\n\n-3.07\n\n\n0.0116 (*)\n\n\n\n\nA vs D\n\n\n0.966\n\n\n0.163\n\n\n-0.20\n\n\n0.9970\n\n\n\n\nB vs C\n\n\n0.608\n\n\n0.112\n\n\n-2.69\n\n\n0.0357 (*)\n\n\n\n\nB vs D\n\n\n0.952\n\n\n0.165\n\n\n-0.28\n\n\n0.9921\n\n\n\n\nC vs D\n\n\n1.566\n\n\n0.278\n\n\n2.52\n\n\n0.0564\n\n\n\n\n\nPart II. Family: gaussian Conditional model: Number of observations: 1088, groups: PATIENT, 919 Dispersion estimate for gaussian family (sigma^2): 0.117\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\n(Intercept)\n\n\n0.464\n\n\n0.124\n\n\n3.75\n\n\n0.00018 (***)\n\n\n\n\nGroup B\n\n\n0.072\n\n\n0.048\n\n\n1.51\n\n\n0.131\n\n\n\n\nGroup C\n\n\n0.103\n\n\n0.041\n\n\n2.50\n\n\n0.012 (*)\n\n\n\n\nGroup D\n\n\n0.096\n\n\n0.046\n\n\n2.09\n\n\n0.037 (*)\n\n\n\n\nAntibiotic (Yes)\n\n\n0.054\n\n\n0.035\n\n\n1.56\n\n\n0.119\n\n\n\n\nMaternal age\n\n\n0.00006\n\n\n0.003\n\n\n0.02\n\n\n0.985\n\n\n\n\nBMI\n\n\n0.0035\n\n\n0.0029\n\n\n1.21\n\n\n0.225\n\n\n\n\nCervical cerclage (Yes)\n\n\n-0.009\n\n\n0.059\n\n\n-0.15\n\n\n0.879\n\n\n\n\nIUGR (Yes)\n\n\n0.074\n\n\n0.064\n\n\n1.16\n\n\n0.246\n\n\n\n\nGestational diabetes (Yes)\n\n\n-0.025\n\n\n0.040\n\n\n-0.63\n\n\n0.532\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.024\n\n\n0.083\n\n\n0.29\n\n\n0.775\n\n\n\n\n\nConfidence level: 0.95 Pairwise comparisons were adjusted using Tukey’s method:\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.072\n\n\n0.048\n\n\n-1.51\n\n\n0.432\n\n\n\n\nA vs C\n\n\n-0.103\n\n\n0.041\n\n\n-2.50\n\n\n0.061 (.)\n\n\n\n\nA vs D\n\n\n-0.096\n\n\n0.046\n\n\n-2.09\n\n\n0.158\n\n\n\n\nB vs C\n\n\n-0.031\n\n\n0.048\n\n\n-0.66\n\n\n0.914\n\n\n\n\nB vs D\n\n\n-0.024\n\n\n0.047\n\n\n-0.51\n\n\n0.956\n\n\n\n\nC vs D\n\n\n0.007\n\n\n0.045\n\n\n0.16\n\n\n0.998\n\n\n\n\n\nData: Phenotypic Resistance Diversity Index (PRDI) by pregnancy outcome groups (A-D) Part I. Family: binomial Number of observations: 1943, groups: PATIENT, 1533 Dispersion estimate for gaussian family (sigma^2): 0.167\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nIntercept\n\n\n-0.348\n\n\n0.483\n\n\n-0.72\n\n\n0.471\n\n\n\n\nGroup B\n\n\n-0.015\n\n\n0.174\n\n\n-0.08\n\n\n0.933\n\n\n\n\nGroup C\n\n\n0.483\n\n\n0.157\n\n\n3.07\n\n\n0.002 (**)\n\n\n\n\nGroup D\n\n\n0.034\n\n\n0.168\n\n\n0.20\n\n\n0.838\n\n\n\n\nAntibiotic (Yes)\n\n\n0.239\n\n\n0.132\n\n\n1.81\n\n\n0.070 (.)\n\n\n\n\nMaternal age\n\n\n-0.035\n\n\n0.012\n\n\n-2.97\n\n\n0.003 (**)\n\n\n\n\nBMI\n\n\n0.061\n\n\n0.012\n\n\n5.04\n\n\n&lt; 1e-6 (***)\n\n\n\n\nCervical cerclage (Yes)\n\n\n0.713\n\n\n0.264\n\n\n2.70\n\n\n0.007 (**)\n\n\n\n\nIUGR (Yes)\n\n\n-0.024\n\n\n0.244\n\n\n-0.10\n\n\n0.923\n\n\n\n\nGestational diabetes (Yes)\n\n\n0.139\n\n\n0.154\n\n\n0.91\n\n\n0.364\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.469\n\n\n0.359\n\n\n1.31\n\n\n0.191\n\n\n\n\n\nConfidence level: 0.95 Results are averaged over the levels of antibiotic treatment during pregnancy; maternal age; BMI; cervical cerclage; IUGR; gestational diabetes; hypertensive disorders. Pairwise comparisons were adjusted using Tukey’s method:\n\n\n\n\n\n\n\n\n\n\n\n\nContrast (OUT_GROUP)\n\n\nOdds ratio\n\n\nSE\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n1.015\n\n\n0.176\n\n\n0.08\n\n\n0.9998\n\n\n\n\nA vs C\n\n\n0.617\n\n\n0.097\n\n\n-3.07\n\n\n0.0116 (*)\n\n\n\n\nA vs D\n\n\n0.966\n\n\n0.163\n\n\n-0.20\n\n\n0.9970\n\n\n\n\nB vs C\n\n\n0.608\n\n\n0.112\n\n\n-2.69\n\n\n0.0357 (*)\n\n\n\n\nB vs D\n\n\n0.952\n\n\n0.165\n\n\n-0.28\n\n\n0.9921\n\n\n\n\nC vs D\n\n\n1.566\n\n\n0.278\n\n\n2.52\n\n\n0.0564\n\n\n\n\n\nPart II. Family: gaussian Conditional model: Number of observations: 1088, groups: PATIENT, 919\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\nPr(&gt;|z|)\n\n\n\n\n\n\n(Intercept)\n\n\n1.0619720\n\n\n0.1300571\n\n\n8.165\n\n\n3.2e-16 (***)\n\n\n\n\nGroup B\n\n\n0.1157758\n\n\n0.0501680\n\n\n2.308\n\n\n0.021012 (*)\n\n\n\n\nGroup C\n\n\n0.1595884\n\n\n0.0432822\n\n\n3.687\n\n\n0.000227 (***)\n\n\n\n\nGroup D\n\n\n0.1388234\n\n\n0.0482995\n\n\n2.874\n\n\n0.004050 (**)\n\n\n\n\nAntibiotic (Yes)\n\n\n0.0400751\n\n\n0.0364133\n\n\n1.101\n\n\n0.271087\n\n\n\n\nMaternal age\n\n\n-0.0007221\n\n\n0.0031796\n\n\n-0.227\n\n\n0.820339\n\n\n\n\nBMI\n\n\n0.0035036\n\n\n0.0030298\n\n\n1.156\n\n\n0.247530\n\n\n\n\nCervical cerclage (Yes)\n\n\n-0.0244801\n\n\n0.0615801\n\n\n-0.398\n\n\n0.690975\n\n\n\n\nIUGR (Yes)\n\n\n0.0480600\n\n\n0.0669054\n\n\n0.718\n\n\n0.472556\n\n\n\n\nGestational diabetes (Yes)\n\n\n-0.0215854\n\n\n0.0422513\n\n\n-0.511\n\n\n0.609434\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.0444680\n\n\n0.0868610\n\n\n0.512\n\n\n0.608690\n\n\n\n\n\nConfidence level: 0.95 Results are averaged over the levels of antibiotic treatment during pregnancy; maternal age; BMI; cervical cerclage; IUGR; gestational diabetes; hypertensive disorders. Pairwise comparisons were adjusted using Tukey’s method:\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.116\n\n\n0.050\n\n\n-2.31\n\n\n0.0969 (.)\n\n\n\n\nA vs C\n\n\n-0.160\n\n\n0.043\n\n\n-3.69\n\n\n0.0014 (**)\n\n\n\n\nA vs D\n\n\n-0.139\n\n\n0.048\n\n\n-2.87\n\n\n0.0215 (*)\n\n\n\n\nB vs C\n\n\n-0.044\n\n\n0.050\n\n\n-0.87\n\n\n0.8211\n\n\n\n\nB vs D\n\n\n-0.023\n\n\n0.049\n\n\n-0.47\n\n\n0.9664\n\n\n\n\nC vs D\n\n\n0.021\n\n\n0.048\n\n\n0.44\n\n\n0.9720\n\n\n\n\n\n\n\nMobile Genetic Element (MGE)\n\n\n\nData: Shannon by pregnancy outcome groups (A-D) Part I. Family: binomial Number of observations: 1943, groups: PATIENT, 1533\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nIntercept\n\n\n-0.906\n\n\n0.504\n\n\n-1.80\n\n\n0.072 (.)\n\n\n\n\nGroup B\n\n\n-0.186\n\n\n0.180\n\n\n-1.04\n\n\n0.300\n\n\n\n\nGroup C\n\n\n0.390\n\n\n0.163\n\n\n2.40\n\n\n0.016\n\n\n\n\nGroup D\n\n\n0.281\n\n\n0.176\n\n\n1.59\n\n\n0.111 (*)\n\n\n\n\nAntibiotic (Yes)\n\n\n0.226\n\n\n0.137\n\n\n1.65\n\n\n0.099\n\n\n\n\nMaternal age\n\n\n-0.014\n\n\n0.012\n\n\n-1.18\n\n\n0.239\n\n\n\n\nBMI\n\n\n0.063\n\n\n0.013\n\n\n5.04\n\n\n&lt; 1e-6 (***)\n\n\n\n\nCervical cerclage (Yes)\n\n\n0.837\n\n\n0.283\n\n\n2.96\n\n\n0.003 (**)\n\n\n\n\nIUGR (Yes)\n\n\n-0.031\n\n\n0.254\n\n\n-0.12\n\n\n0.904\n\n\n\n\nGestational diabetes (Yes)\n\n\n-0.167\n\n\n0.159\n\n\n-1.05\n\n\n0.293\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.144\n\n\n0.363\n\n\n0.40\n\n\n0.692\n\n\n\n\n\nEstimated marginal probability on the response scale Confidence level: 0.95\n\n\n\n\n\n\n\n\n\n\n\n\nOUT_GROUP\n\n\nProbability\n\n\nSE\n\n\nLower 95% CI\n\n\nUpper 95% CI\n\n\n\n\n\n\nA\n\n\n0.663\n\n\n0.062\n\n\n0.534\n\n\n0.772\n\n\n\n\nB\n\n\n0.620\n\n\n0.068\n\n\n0.480\n\n\n0.743\n\n\n\n\nC\n\n\n0.744\n\n\n0.051\n\n\n0.632\n\n\n0.831\n\n\n\n\nD\n\n\n0.723\n\n\n0.056\n\n\n0.602\n\n\n0.818\n\n\n\n\n\nConfidence level: 0.95 Results are averaged over the levels of antibiotic treatment during pregnancy; maternal age; BMI; cervical cerclage; IUGR; gestational diabetes; hypertensive disorders. Pairwise comparisons were adjusted using Tukey’s method:\n\n\n\n\n\n\n\n\n\n\n\n\nContrast (OUT_GROUP)\n\n\nOdds ratio\n\n\nSE\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n1.205\n\n\n0.217\n\n\n1.04\n\n\n0.7285\n\n\n\n\nA vs C\n\n\n0.677\n\n\n0.110\n\n\n-2.40\n\n\n0.0771 (.)\n\n\n\n\nA vs D\n\n\n0.755\n\n\n0.133\n\n\n-1.59\n\n\n0.3819\n\n\n\n\nB vs C\n\n\n0.562\n\n\n0.108\n\n\n-3.00\n\n\n0.0143 (*)\n\n\n\n\nB vs D\n\n\n0.627\n\n\n0.114\n\n\n-2.57\n\n\n0.0505 (.)\n\n\n\n\nC vs D\n\n\n1.115\n\n\n0.205\n\n\n0.59\n\n\n0.9342\n\n\n\n\n\nPart II. Family: gaussian Conditional model: Number of observations: 1123, groups: PATIENT, 949 Dispersion estimate for gaussian family (sigma^2): 0.165\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nIntercept\n\n\n1.033\n\n\n0.157\n\n\n6.60\n\n\n&lt; 1e-10 (***)\n\n\n\n\nGroup B\n\n\n0.027\n\n\n0.060\n\n\n0.44\n\n\n0.661\n\n\n\n\nGroup C\n\n\n0.109\n\n\n0.052\n\n\n2.10\n\n\n0.036 (*)\n\n\n\n\nGroup D\n\n\n-0.095\n\n\n0.057\n\n\n-1.67\n\n\n0.096 (.)\n\n\n\n\nAntibiotic (Yes)\n\n\n0.048\n\n\n0.044\n\n\n1.09\n\n\n0.274\n\n\n\n\nMaternal age\n\n\n-0.008\n\n\n0.004\n\n\n-2.17\n\n\n0.030 (*)\n\n\n\n\nBMI\n\n\n0.010\n\n\n0.004\n\n\n2.66\n\n\n0.0078 (**)\n\n\n\n\nCervical cerclage (Yes)\n\n\n-0.074\n\n\n0.074\n\n\n-1.00\n\n\n0.316\n\n\n\n\nIUGR (Yes)\n\n\n-0.017\n\n\n0.078\n\n\n-0.22\n\n\n0.823\n\n\n\n\nGestational diabetes (Yes)\n\n\n0.040\n\n\n0.052\n\n\n0.78\n\n\n0.434\n\n\n\n\nHypertensive disorders (Yes)\n\n\n0.270\n\n\n0.109\n\n\n2.48\n\n\n0.013 (*)\n\n\n\n\n\nConfidence level: 0.95 Results are averaged over the levels of antibiotic treatment during pregnancy; maternal age; BMI; cervical cerclage; IUGR; gestational diabetes; hypertensive disorders. Pairwise comparisons were adjusted using Tukey’s method:\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.027\n\n\n0.060\n\n\n-0.44\n\n\n0.972\n\n\n\n\nA vs C\n\n\n-0.109\n\n\n0.052\n\n\n-2.10\n\n\n0.155\n\n\n\n\nA vs D\n\n\n0.095\n\n\n0.057\n\n\n1.67\n\n\n0.342\n\n\n\n\nB vs C\n\n\n-0.083\n\n\n0.061\n\n\n-1.36\n\n\n0.528\n\n\n\n\nB vs D\n\n\n0.122\n\n\n0.059\n\n\n2.07\n\n\n0.163\n\n\n\n\nC vs D\n\n\n0.204\n\n\n0.056\n\n\n3.63\n\n\n\n\n\n(**)\n\n\n\n\n\n\n\n\n\n\nGLMMs Diagnostics\n\n Model Diagnostic"
  },
  {
    "objectID": "Reports/R3.html",
    "href": "Reports/R3.html",
    "title": "\nβ-diversity comparison across CSTs\n",
    "section": "",
    "text": "Significance codes: () p &lt; 0.001, () p &lt; 0.01, () p &lt; 0.05, (.) p &lt; 0.1\n\n\nβ-diversity comparison across CSTs\n\n\nReport 3: PERMANOVA analysis of β-diversity across vaginal community state types (CSTs) in inclusion (IN) and delivery (DR) samples.\n\n\n\nSpecies\n\n\n\nPermutation test for adonis under reduced model Permutation: free Number of permutations: 999 formula = distance ~ CST  data: IN Samples\n\n\n\n\n\n\n\n\n\n\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nModel 4\n\n\n187.26\n\n\n0.48595\n\n\n245.79\n\n\n0.001 (***)\n\n\n\n\nResidual 1040\n\n\n198.09\n\n\n0.51405\n\n\n\n\n\n\n\n\nTotal 1044\n\n\n385.35\n\n\n1.00000\n\n\n\n\n\n\n\n\n\ndata: DR Samples\n\n\n\n\n\n\n\n\n\n\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nModel 4\n\n\n150.20\n\n\n0.43066\n\n\n171.52\n\n\n0.001 (***)\n\n\n\n\nResidual 907\n\n\n198.56\n\n\n0.56934\n\n\n\n\n\n\n\n\nTotal 911\n\n\n348.76\n\n\n1.00000\n\n\n\n\n\n\n\n\n\n\n\nAntibiotic Resistance Genes (ARG)\n\n\n\nPermutation test for adonis under reduced model Permutation: free Number of permutations: 999 formula = distance ~ CST\n\n\nData: genes detected IN Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nModel\n\n\n4\n\n\n13.485\n\n\n0.06883\n\n\n11.253\n\n\n0.001 (***)\n\n\n\n\nResidual\n\n\n609\n\n\n182.445\n\n\n0.93117\n\n\n\n\n\n\n\n\nTotal\n\n\n613\n\n\n195.930\n\n\n1.00000\n\n\n\n\n\n\n\n\n\nData: genes detected DR Samples\n\n\n\n\n\n\n\n\n\n\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nModel 4\n\n\n9.757\n\n\n0.06153\n\n\n7.8352\n\n\n0.001(***)\n\n\n\n\nResidual 478\n\n\n148.816\n\n\n0.93847\n\n\n\n\n\n\n\n\nTotal 482\n\n\n158.574\n\n\n1.00000\n\n\n\n\n\n\n\n\n\n\n\nMobile Genetic Element (MGE)\n\n\n\nPermutation test for adonis under reduced model Permutation: free Number of permutations: 999 formula = distance ~ CST\n\n\nData: genes detected IN Samples\n\n\n\n\n\n\n\n\n\n\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nModel 4\n\n\n17.527\n\n\n0.09129\n\n\n15.596\n\n\n0.001 (***)\n\n\n\n\nResidual 621\n\n\n174.473\n\n\n0.90871\n\n\n\n\n\n\n\n\nTotal 625\n\n\n192.000\n\n\n1.00000\n\n\n\n\n\n\n\n\n\nData: genes detected DR Samples\n\n\n\n\n\n\n\n\n\n\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nModel 4\n\n\n12.77\n\n\n0.08088\n\n\n11.043\n\n\n0.001 (***)\n\n\n\n\nResidual 502\n\n\n145.12\n\n\n0.91912\n\n\n\n\n\n\n\n\nTotal 506\n\n\n157.89\n\n\n1.00000"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "\nBacterial Community Structure Shapes the Vaginal Resistome During Pregnancy\n",
    "section": "",
    "text": "Supplementary data\n\n\nBacterial Community Structure Shapes the Vaginal Resistome During Pregnancy\n\n\n\nArticle authored by:\nNassim Boutouchent, Agnes Baud, Asmaa Tazi, Luce Landraud, InSPIRe Consortium,\nLaurent Mandelbrot, Claire Poyart, Sean P. Kennedy\n\n\n\n\nThis page provides an interactive visualization of the supplementary data associated with the article. Use the navigation bar to explore figures, tables, and statistical reports.  For any questions related to this repository, please use the Contact section.\n\n\n\n\n\n\n\n\n\nNoteLicence information\n\n\n\n© 2026 Institut Pasteur - All rights reserved.\nThis repository contains supplementary material associated with a scientific publication.\nAll content will be licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0) upon publication."
  },
  {
    "objectID": "Figures/S3S12.html",
    "href": "Figures/S3S12.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Figure 3.\n\n\n\n\nSupplementary Figure 3. Cross-validation of antibiotic resistance gene (ARG) detection and diversity using CARD.\n\n\nRelative abundance distribution of the top 10 antibiotic resistance genes (ARGs) (a) and corresponding antibiotic resistance classes (b) across all ARG-positive samples. (c) Prevalence and average abundance of the top 20 antibiotic resistance genes detected using the CARD database. Each bubble represents one of the 20 most abundant ARGs: horizontal position shows mean relative abundance (log scale), bubble size reflects gene prevalence, and bubble color corresponds to antibiotic class.\n\n\n\n\nSupplementary Figure 12.\n\n\n\n\nSupplementary Figure 12. Cross-validation of antibiotic resistance gene (ARG) detection and diversity using an independent external cohort of pregnant women.\n\n\nVisual comparison between the InSPIRe cohort and an external dataset (European Nucleotide Archive accession PRJEB34536) (left to right). Bubble plots show the 10 most abundant and prevalent ARGs, where bubble size represents prevalence and colors indicate antibiotic resistance classes (a, b). Panels (c, d) show the relative abundance of detected antibiotic resistance classes. Panels (e, f) show boxplots of the Shannon diversity index for ARGs across CSTs."
  },
  {
    "objectID": "Figures/S1S5S6S11.html",
    "href": "Figures/S1S5S6S11.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Figure 1.\n\n\n\n\nSupplementary Figure 1. Taxonomic composition of vaginal samples.\n\n\nTaxonomic composition of all samples (n = 1,957) and of the subset collected at inclusion (IN; n = 1,045) and at delivery (DR; n = 912). The top 14 most abundant species are shown; all remaining species were grouped under “Other”.\n\n\n\n\nSupplementary Figure 6.\n\n\n\n\nSupplementary Figure 6. Composition of microbial taxa, ARGs, and MGEs across vaginal CSTs.\n\n\nRelative abundance of microbial taxa (a), antibiotic resistance genes (ARGs) (b), and mobile genetic element (MGE) families (c) across community state types (CSTs).\n\n\n\n\nSupplementary Figure 7.\n\n\n\n\nSupplementary Figure 7. Composition of microbial taxa, ARGs, and MGEs across vaginal CSTs.\n\n\nHeatmaps of MaAsLin2 effect sizes for (a) microbial species, (b) antibiotic resistance genes (ARGs), (c) mobile genetic elements (MGEs) across CSTs, with CST I set as reference. All models included patient ID as a random effect to account for repeated sampling. The color scale indicates the magnitude and direction of the effect size (positive values in brown for enrichment, negative values in blue for depletion). Significant results were annotated with an asterisk mark (* for an adjusted p-value &lt; 0.1; and ** for adjusted p-value &lt; 0.05)\n\n\n\n\nSupplementary Figure 12.\n\n\n\n\nSupplementary Figures 12. Differential abundance of taxa, ARGs and MGE across clinical groups (A-D).\n\n\nHeatmaps of MaAsLin2 effect sizes for (a) microbial species, (b) antibiotic resistance genes (ARGs), (c) mobile genetic elements (MGEs) across clinical groups (A-C), with group set as reference. A: Full Term (Control); B: Full Term Early Membrane Rupture (PROM); (C) Preterm Labor (PTL); (D) Premature Early Membrane Rupture (PPROM). This figure extends the visualization to all covariates included in the models. The color scale indicates the magnitude and direction of the effect size (positive values in brown for enrichment, negative values in blue for depletion). Significant results were annotated with an asterisk mark (* for an adjusted p-value &lt; 0.1; and ** for adjusted p-value &lt; 0.05)"
  },
  {
    "objectID": "data.html",
    "href": "data.html",
    "title": "VagResist",
    "section": "",
    "text": "Raw read count tables\n Download (ZIP) \n\n\nNormilized read count tables\n Download (ZIP) \n\n\nMetadata\n Download (ZIP) \n\n\nPhenoARGTree (for PRDI calculation)\n Download \n\n\nInSPIRe Moonbase 16S Tree (for phylogenetic diversity calculation)\n Download"
  },
  {
    "objectID": "consortium.html",
    "href": "consortium.html",
    "title": "InSPIRE Consortium",
    "section": "",
    "text": "InSPIRE Consortium\n\n\nMicrobiology\n\n\n\nClaire Poyart U 1016 Institut Cochin Bacteria and Perinatality, FHU Prema, Université Paris Cité, APHP Centre, NRC des Streptocoques Cochin\n\n\nAsmaa Tazi U 1016 Institut Cochin Bacteria and Perinatality, FHU Prema Université Paris Cité, APHP Centre, NRC des Streptocoques Cochin\n\n\nCéline Plainvert NRC des Streptocoques, APHP Cochin\n\n\nLuce Landraud Inserm 1137 IAME Université Paris Cité, APHP Louis Mourier Microbiology\n\n\nClermont Olivier Inserm 1137 IAME Université Paris Cité\n\n\nNathalie Grall APHP Bichat Microbiology\n\n\n\nMethodology\n\n\n\nPierre-Yves Ancel, APHP URC-CIC Cochin-Necker Mère-Enfant – U1153 EPOPé, FHU Prema\n\n\nLaurence Lecomte, APHP DRCI, FHU Prema\n\n\nHendy Abdoul, APHP URC-CIC Cochin-Necker Mère-Enfant, FHU Prema\n\n\nJessica Rousseau, Data Manager, APHP URC-CIC Cochin-Necker Mère-Enfant\n\n\n\nObstetrics\n\n\n\nLaurent Mandelbrot, APHP Louis Mourier Obstetrics/Gynecology, FHU Prema, Inserm 1137 IAME Université Paris Cité\n\n\nFrançois Goffinet, APHP Cochin Port-Royal Obstetrics/Gynecology, FHU Prema, U1153 EPOPé, Université Paris Cité\n\n\nDominique Luton APHP Bichat Obstetrics/Gynecology, Université Paris Cité\n\n\n\nNeonatalogy\n\n\n\nPierre-Henri Jarreau, APHP Cochin Port-Royal, Neonatalogy, FHU Prema, Université Paris Cité\n\n\nLuc Desfrère, APHP Louis Mourier Neonatalogy, FHU Prema\n\n\nLahçene Allal, APHP Bichat Neonatalogy, FHU Prema\n\n\n\nMetagenomics\n\n\n\nSean Kennedy, Institut Pasteur, Université Paris Cité, Département de biologie computationnelle, F-75015 Paris, France\n\n\nAgnes Baud, Institut Pasteur, Université Paris Cité, Département de biologie computationnelle, F-75015 Paris, France\n\n\nKenzo-Hugo Hillion, Institut Pasteur, Université Paris Cité, Département de biologie computationnelle, F-75015 Paris, France\n\n\n\nGenomics\n\n\n\nCéline Méhats, Institut Cochin Inserm U 1016, UMR CNRS 8104, Université Paris Cité, « Des gamètes à la naissance », Génomique, épigénétique et physiopathologie de la reproduction, FHU Prema\n\n\nFrédéric Batteux Institut Cochin Inserm U 1016, UMR CNRS 8104, Université Paris Cité, « Des gamètes à la naissance », - Stress oxydant, prolifération cellulaire et inflammation, FHU Prema\n\n\n\nProgram manager\n\n\n\nVéronique Tessier, APHP DRCI\n\n\n\nData monitoring and management\n\n\n\nSinthiya Sivanesan, APHP URC/CIC Necker Cochin, FHU Prema\n\n\nHélène Jabbarian, APHP Louis Mourier, URC Paris-Nord, FHU Prema\n\n\n\nIndustrial partner\n\n\n\nChristophe Pannetier, BforCure\n\n\nLaura Lesimple, Université Paris Cité, Institut Cochin, Inserm U1016, CNRS UMR8104, Bacteria and Perinatality team, BforCure"
  },
  {
    "objectID": "contact.html",
    "href": "contact.html",
    "title": "Contact",
    "section": "",
    "text": "For any questions related to this repository, please contact:\nNassim Boutouchent\nnassim.boutouchent@chu-rouen.fr\nSean Kennedy\nsean.kennedy@pasteur.fr"
  },
  {
    "objectID": "Figures/S10.html",
    "href": "Figures/S10.html",
    "title": "VagResist",
    "section": "",
    "text": "PRDI was calculated for both synthetical and biological samples as the total length of the branches of the smallest subtree connecting the observed ARGs to the root of the PhenoARGTree, following the Faith’s phylogenetic diversity formulation. This calculation was performed using the faith_pd () function from the scikit-bio library (v0.6.3).\n\n\n\nPhenoARGTree\n\n\nView interactive tree on iTOL\n\n\n\nConceptual validation of the PRDI was carried out using synthetic samples to distinguish between redundant augmentation of genes sharing the same resistance phenotype and “True” functional diversification. (addition of genes carrying distinct phenotypes). Starting with an initial subset of 50 randomly selected ARGs with unique phenotypes, the total number of genes was increased in increments of +5, +10, +20, +40, +80, and +100%, either by adding genes with the same phenotype (case 1: redundancy) or genes with new phenotypes (case 2: diversification). The α-diversity indices, including richness and Shannon, were calculated using scikit-bio (v0.6.3). The PRDI difference between the two cases as a function of the percentage added was modeled using the ordinary least squares method with robust standard errors (HC3)."
  },
  {
    "objectID": "Figures/S10.html#phenotypic-resistance-diversity-index-prdi---conceptual-validation",
    "href": "Figures/S10.html#phenotypic-resistance-diversity-index-prdi---conceptual-validation",
    "title": "VagResist",
    "section": "",
    "text": "PRDI was calculated for both synthetical and biological samples as the total length of the branches of the smallest subtree connecting the observed ARGs to the root of the PhenoARGTree, following the Faith’s phylogenetic diversity formulation. This calculation was performed using the faith_pd () function from the scikit-bio library (v0.6.3).\n\n\n\nPhenoARGTree\n\n\nView interactive tree on iTOL\n\n\n\nConceptual validation of the PRDI was carried out using synthetic samples to distinguish between redundant augmentation of genes sharing the same resistance phenotype and “True” functional diversification. (addition of genes carrying distinct phenotypes). Starting with an initial subset of 50 randomly selected ARGs with unique phenotypes, the total number of genes was increased in increments of +5, +10, +20, +40, +80, and +100%, either by adding genes with the same phenotype (case 1: redundancy) or genes with new phenotypes (case 2: diversification). The α-diversity indices, including richness and Shannon, were calculated using scikit-bio (v0.6.3). The PRDI difference between the two cases as a function of the percentage added was modeled using the ordinary least squares method with robust standard errors (HC3)."
  },
  {
    "objectID": "Figures/S2S7.html",
    "href": "Figures/S2S7.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Figure 2.\n\n\n\n\nSupplementary Figure 2. Transition frequency of dominant vaginal taxonomic profile between inclusion (IN) and delivery (DR) samples.\n\n\nHeatmap showing the frequency transition matrix in dominant species between inclusion (IN) and delivery (DR) samples. Taxa were classified as dominant if they constituted ≥ 30 % of the profile. ‘other’ refers to the number of samples with a different dominant taxon. Rows represent the dominant species at inclusion and columns at delivery. Values correspond to the number of individuals with a given transition. Statistical significance of inter-species differences in stability rate was assessed using a Monte Carlo permutation test on the χ² statistic.\n\n\n\n\nSupplementary Figure 8.\n\n\n\n\nSupplementary Figure 8. Paired-samples comparisons of α-diversity for ARGs and MGEs across CST.\n\n\nEach panel shows patient-matched diversity metrics comparing samples transitioning between community state types (CSTs): from CST I (a–c) or from CSTs I, II or V to CST III or IV (d–f).Lines connect values from the same individual. α-diversity metrics : observed richness (a, d), Shannon index (b, e), and Simpson index (c, f). Panels g–i and j–l depicts the same comparisons for mobile genetic elements (MGEs)."
  },
  {
    "objectID": "Figures/S4S8S9.html",
    "href": "Figures/S4S8S9.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Figure 4.\n\n\n\n\nSupplementary Figure 4. Extended phylogenetic projection of ARG-species associations in the vaginal microbiota.\n\n\nA 16S rDNA-based tree of vaginal microbial species annotated with associated antibiotic resistance classes. Tree coloring indicates bacterial order (legend, upper right). For this representation, all species-ARG pairs within a single sample were displayed. ARGs (legend, left) are displayed along concentric arcs by antibiotic class.\nView interactive tree on iTOL\n\n\n\n\nSupplementary Figure 9.\n\n\n\n\nSupplementary Figure 9. Co-abundance network of microbial species, antibiotic resistance genes (ARG), and mobile genetic elements (MGE).\n\n\n(a) Network constructed from the 20 most abundant microbial species and 50 clinically relevant antimicrobial resistance genes (ARGs). (b) Network including the same 20 microbial species and ARGs with the addition of MGEs. Nodes represent microbial species (blue), ARGs (pink), and MGEs (orange), with node size scaled by average relative abundance (%). Edges indicate significant correlations: blue edges represent positive correlations (ρ &gt; 0.2, P &lt; 0.01), and orange edges represent negative correlations (ρ &lt; -0.2, P &lt; 0.01); edge thickness is proportional to correlation strength.\n\n\n\n\nSupplementary Figure 10.\n\n\n\n\nSupplementary Figure 9. Co-abundance matrices between microbial species, ARGs, and MGEs.\n\n\n(a) SparCC-based correlation matrix between the 20 most abundant microbial species and the 50 most abundant antibiotic resistance genes (ARGs). (b) SparCC-based correlation matrix beetween the same microbial species and the 50 moste abundant ARGs and mobile genetic elements (MGEs). Matrix was clustered with the “average” linkage method."
  },
  {
    "objectID": "Reports/R1R2.html",
    "href": "Reports/R1R2.html",
    "title": "\nα-diversity comparison across CSTs (InSPIRe cohort)\n",
    "section": "",
    "text": "Significance codes: *** p &lt; 0.001, ** p &lt; 0.01, * p &lt; 0.05, . p &lt; 0.1\n\n\nα-diversity comparison across CSTs (InSPIRe cohort)\n\n\n\nReport 1\n\n\nReport 1: Comparison of species, ARG and MGE α-diversity metrics across vaginal community state types (CST).\n\n\n\nSpecies\n\n\n\nData: Shannon by CST Kruskal-Wallis chi-squared = 380.66, df = 4, p-value &lt; 2.2e-16 (***) Pairwise comparisons using Dunn’s test p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n&lt; 2e-16 (***)\n\n\n-\n\n\n-\n\n\n-\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n-\n\n\n-\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n0.2205\n\n\n&lt; 2e-16 (***)\n\n\n-\n\n\n\n\nCST V\n\n\n&lt; 2e-16 (***)\n\n\n0.2532\n\n\n&lt; 2e-16 (***)\n\n\n0.0756\n\n\n\n\n\nData: Phylogenetic diversity (PD) by CST Kruskal-Wallis chi-squared = 86.01, df = 4, p-value &lt; 2.2e-16 (***) Pairwise comparisons using Dunn’s test p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n0.0056 (**)\n\n\n-\n\n\n-\n\n\n-\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n0.4832\n\n\n-\n\n\n-\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n0.0018 (**)\n\n\n&lt; 2e-16 (***)\n\n\n-\n\n\n\n\nCST V\n\n\n0.0359 (*)\n\n\n0.3995\n\n\n0.3984\n\n\n0.0016\n\n\n\n\n\n\n\nAntibiotic Resistance Genes (ARG)\n\n\n\nData: Shannon by CST Kruskal–Wallis chi-squared = 196.57, df = 4, p-value &lt; 2.2e-16 (***) Pairwise comparisons using Dunn’s test p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n0.0046 (**)\n\n\n–\n\n\n–\n\n\n–\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n–\n\n\n–\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n0.0002 (**)\n\n\n0.0400 (***)\n\n\n–\n\n\n\n\nCST V\n\n\n0.0100 (*)\n\n\n0.4964\n\n\n&lt; 2e-16 (***)\n\n\n0.0007 (***)\n\n\n\n\n\nData: Phenotypic Resistance Diversity Index (PRDI) by CST Kruskal–Wallis chi-squared = 341.45, df = 4, p-value &lt; 2.2e-16 Pairwise comparisons using Dunn’s test p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n0.0001 (***)\n\n\n–\n\n\n–\n\n\n–\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n–\n\n\n–\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n0.0033 (**)\n\n\n–\n\n\n\n\nCST V\n\n\n0.0016 (**)\n\n\n0.3829\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n\n\n\n\n\nMobile Genetic Element (MGE)\n\n\n\nData: Shannon by CST Kruskal–Wallis chi-squared = 281.99, df = 4, p-value &lt; 2.2e-16 (***) Pairwise comparisons using Dunn’s test p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n0.1485\n\n\n–\n\n\n–\n\n\n–\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n–\n\n\n–\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n0.0002 (***)\n\n\n&lt; 2e-16 (***)\n\n\n–\n\n\n\n\nCST V\n\n\n0.0135 (*)\n\n\n0.1358\n\n\n&lt; 2e-16 (***)\n\n\n0.0319 (*)\n\n\n\n\n\n\n\nReport 2\n\n\nReport 2: Association between vaginal community state Type (CST) and gene detection.\n\n\n\nAntibiotic Resistance Genes (ARG)\n\n\n\n\nPearson’s Chi-squared test chi-squared = 593.01, df = 4, p-value &lt; 2.2e-16 (***) p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n2.8e-10 (***)\n\n\n-\n\n\n-\n\n\n-\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n&lt; 2e-16 (***)\n\n\n-\n\n\n-\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n1.2e-06 (***)\n\n\n3.3e-09 (***)\n\n\n-\n\n\n\n\nCST V\n\n\n1.2e-06 (***)\n\n\n0.61\n\n\n&lt; 2e-16 (***)\n\n\n1.2e-06 (***)\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST Type\n\n\nAbsence\n\n\nPresence\n\n\n\n\n\n\nCST I\n\n\n566\n\n\n184\n\n\n\n\nCST II\n\n\n70\n\n\n76\n\n\n\n\nCST III\n\n\n55\n\n\n454\n\n\n\n\nCST IV\n\n\n115\n\n\n332\n\n\n\n\nCST V\n\n\n54\n\n\n51\n\n\n\n\n\n\n\nMobile Genetic Element (MGE)\n\n\n\nPearson’s Chi-squared test chi-squared = 263.96, df = 4, p-value &lt; 2.2e-16 (***) p-value adjustment method: Benjamini-Hochberg (BH)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST I\n\n\nCST II\n\n\nCST III\n\n\nCST IV\n\n\n\n\n\n\nCST II\n\n\n9.8e-07 (***)\n\n\n-\n\n\n-\n\n\n-\n\n\n\n\nCST III\n\n\n&lt; 2e-16 (***)\n\n\n0.00024 (***)\n\n\n-\n\n\n-\n\n\n\n\nCST IV\n\n\n&lt; 2e-16 (***)\n\n\n0.00105 (**)\n\n\n0.65207\n\n\n-\n\n\n\n\nCST V\n\n\n0.04029 (*)\n\n\n0.08014 (.)\n\n\n8.4e-08 (***)\n\n\n6.0e-07 (***)\n\n\n\n\n\n\n\n\n\n\n\n\n\nCST\n\n\nAbsence\n\n\nPresence\n\n\n\n\n\n\nCST I\n\n\n475\n\n\n275\n\n\n\n\nCST II\n\n\n59\n\n\n87\n\n\n\n\nCST III\n\n\n122\n\n\n387\n\n\n\n\nCST IV\n\n\n113\n\n\n334\n\n\n\n\nCST V\n\n\n55\n\n\n50"
  },
  {
    "objectID": "Reports/R4R5.html",
    "href": "Reports/R4R5.html",
    "title": "VagResist",
    "section": "",
    "text": "Significance codes: *** p &lt; 0.001, ** p &lt; 0.01, * p &lt; 0.05, . p &lt; 0.1\n\n\n\nReport 4\n\n\nReport 4: Univariate Log-transformed Gaussian mixed-effects models of species α-diversity across pregnancy outcome groups (A-D).\n\n\nModel estimates\n\n\nFamily: gaussian Formula: diversity_metric ~ pregnancy outcome group (A-D) + (1 | patient)\n\n\nData: Shannon by pregnancy outcome groups (A-D) Number of observations: 1957; groups: PATIENT, 1547 Dispersion estimate for gaussian family (sigma^2): 0.138\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nIntercept\n\n\n0.825\n\n\n0.020\n\n\n41.25\n\n\n&lt; 2e-16 (***)\n\n\n\n\nGroup B\n\n\n-0.034\n\n\n0.032\n\n\n-1.07\n\n\n0.286\n\n\n\n\nGroup C\n\n\n0.007\n\n\n0.030\n\n\n0.24\n\n\n0.809\n\n\n\n\nGroup D\n\n\n0.181\n\n\n0.030\n\n\n6.01\n\n\n1.86e-09 (***)\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n0.034\n\n\n0.032\n\n\n1.07\n\n\n0.710\n\n\n\n\nA vs C\n\n\n-0.007\n\n\n0.030\n\n\n-0.24\n\n\n0.995\n\n\n\n\nA vs D\n\n\n-0.181\n\n\n0.030\n\n\n-6.01\n\n\n&lt; 0.0001 (***)\n\n\n\n\nB vs C\n\n\n-0.041\n\n\n0.034\n\n\n-1.23\n\n\n0.610\n\n\n\n\nB vs D\n\n\n-0.215\n\n\n0.034\n\n\n-6.40\n\n\n&lt; 0.0001 (***)\n\n\n\n\nC vs D\n\n\n-0.173\n\n\n0.032\n\n\n-5.43\n\n\n&lt; 0.0001 (***)\n\n\n\n\n\n Data: Phylogenetic Diversity (PD) by pregnancy outcome groups (A-D) Family: gaussian Number of observations: 1957; groups: PATIENT, 1547 Dispersion estimate for gaussian family (sigma^2): 0.178\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nIntercept\n\n\n3.575\n\n\n0.022\n\n\n162.58\n\n\n&lt; 2e-16 (***)\n\n\n\n\nGroup B\n\n\n0.045\n\n\n0.035\n\n\n1.28\n\n\n0.200\n\n\n\n\nGroup C\n\n\n0.145\n\n\n0.033\n\n\n4.36\n\n\n1.31e-05 (***)\n\n\n\n\nGroup D\n\n\n0.221\n\n\n0.033\n\n\n6.68\n\n\n2.35e-11 (***)\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.045\n\n\n0.035\n\n\n-1.28\n\n\n0.575\n\n\n\n\nA vs C\n\n\n-0.145\n\n\n0.033\n\n\n-4.36\n\n\n0.0001 (***)\n\n\n\n\nA vs D\n\n\n-0.221\n\n\n0.033\n\n\n-6.68\n\n\n&lt; 0.0001 (***)\n\n\n\n\nB vs C\n\n\n-0.100\n\n\n0.037\n\n\n-2.72\n\n\n0.0337 (*)\n\n\n\n\nB vs D\n\n\n-0.176\n\n\n0.037\n\n\n-4.79\n\n\n&lt; 0.0001 (***)\n\n\n\n\nC vs D\n\n\n-0.076\n\n\n0.035\n\n\n-2.17\n\n\n0.133\n\n\n\n\n\n\n\nReport 5\n\n\nReport 5: Univariate Hurdle mixed-effects models (binomial and log-transformed Gaussian) assessing ARGs and MGEs detection and diversity across pregnancy outcome groups (A-D).\n\n\n\n\nModel estimates\n\n\n\n\nFormula: diversity_metric ~ outcome_group + (1 | patient)\n\n\n\nAntibiotic Resistance Genes (ARG)\n\n\n\nData: Shannon by pregnancy outcome groups (A-D) Part I. Family: binomial Number of observations: 1947, groups: PATIENT, 1547\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\n(Intercept)\n\n\n0.094\n\n\n0.100\n\n\n0.94\n\n\n0.346\n\n\n\n\nGroup B\n\n\n0.038\n\n\n0.161\n\n\n0.24\n\n\n0.811\n\n\n\n\nGroup C\n\n\n0.545\n\n\n0.154\n\n\n3.54\n\n\n0.000405 (***)\n\n\n\n\nGroup D\n\n\n0.255\n\n\n0.150\n\n\n1.70\n\n\n0.089 (.)\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nOdds ratio\n\n\nSE\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n0.962\n\n\n0.155\n\n\n-0.239\n\n\n0.995\n\n\n\n\nA vs C\n\n\n0.580\n\n\n0.089\n\n\n-3.537\n\n\n0.0023 (**)\n\n\n\n\nA vs D\n\n\n0.775\n\n\n0.116\n\n\n-1.701\n\n\n0.323\n\n\n\n\nB vs C\n\n\n0.603\n\n\n0.104\n\n\n-2.939\n\n\n0.0173 (*)\n\n\n\n\nB vs D\n\n\n0.805\n\n\n0.136\n\n\n-1.284\n\n\n0.573\n\n\n\n\nC vs D\n\n\n1.336\n\n\n0.215\n\n\n1.801\n\n\n0.273\n\n\n\n\n\nPart II. Family: gaussian Number of observations: 1097, groups: PATIENT, 928 Dispersion estimate for gaussian family (sigma^2): 0.117\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\n(Intercept)\n\n\n0.560\n\n\n0.028\n\n\n19.86\n\n\n&lt; 2e-16 (***)\n\n\n\n\nGroup B\n\n\n0.098\n\n\n0.045\n\n\n2.20\n\n\n0.028 (*)\n\n\n\n\nGroup C\n\n\n0.112\n\n\n0.040\n\n\n2.78\n\n\n0.0055 (**)\n\n\n\n\nGroup D\n\n\n0.130\n\n\n0.041\n\n\n3.18\n\n\n0.0015 (**)\n\n\n\n\n\n Confidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.098\n\n\n0.045\n\n\n-2.20\n\n\n0.125\n\n\n\n\nA vs C\n\n\n-0.112\n\n\n0.041\n\n\n-2.78\n\n\n0.0286 (*)\n\n\n\n\nA vs D\n\n\n-0.130\n\n\n0.041\n\n\n-3.18\n\n\n0.0082 (**)\n\n\n\n\nB vs C\n\n\n-0.014\n\n\n0.045\n\n\n-0.31\n\n\n0.990\n\n\n\n\nB vs D\n\n\n-0.032\n\n\n0.046\n\n\n-0.70\n\n\n0.898\n\n\n\n\nC vs D\n\n\n-0.018\n\n\n0.042\n\n\n-0.43\n\n\n0.973\n\n\n\n\n\n Data: Phenotypic Resistance Diversity Index (PRDI) by pregnancy outcome groups (A-D) Part I. Family: binomial Number of observations: 1947, groups: PATIENT, 1547\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\n(Intercept)\n\n\n0.094\n\n\n0.100\n\n\n0.94\n\n\n0.346\n\n\n\n\nGroup B\n\n\n0.038\n\n\n0.161\n\n\n0.24\n\n\n0.811\n\n\n\n\nGroup C\n\n\n0.545\n\n\n0.154\n\n\n3.54\n\n\n0.00041 (***)\n\n\n\n\nGroup D\n\n\n0.255\n\n\n0.150\n\n\n1.70\n\n\n0.089 (.)\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nOdds ratio\n\n\nSE\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n0.962\n\n\n0.155\n\n\n-0.24\n\n\n0.995\n\n\n\n\nA vs C\n\n\n0.580\n\n\n0.089\n\n\n-3.54\n\n\n0.0023 (**)\n\n\n\n\nA vs D\n\n\n0.775\n\n\n0.116\n\n\n-1.70\n\n\n0.323\n\n\n\n\nB vs C\n\n\n0.603\n\n\n0.104\n\n\n-2.94\n\n\n0.017 (*)\n\n\n\n\nB vs D\n\n\n0.805\n\n\n0.136\n\n\n-1.28\n\n\n0.573\n\n\n\n\nC vs D\n\n\n1.336\n\n\n0.215\n\n\n1.80\n\n\n0.273\n\n\n\n\n\nPart II. Family: gaussian Number of observations: 1097, groups: PATIENT, 928 Dispersion estimate for gaussian family (sigma^2): 0.166\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\n(Intercept)\n\n\n1.130\n\n\n0.029\n\n\n38.33\n\n\n&lt; 2e-16 (***)\n\n\n\n\nGroup B\n\n\n0.135\n\n\n0.047\n\n\n2.86\n\n\n0.0042 (**)\n\n\n\n\nGroup C\n\n\n0.165\n\n\n0.042\n\n\n3.91\n\n\n9.29e-05 (***)\n\n\n\n\nGroup D\n\n\n0.157\n\n\n0.043\n\n\n3.67\n\n\n0.00024 (***)\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.135\n\n\n0.047\n\n\n-2.86\n\n\n0.022 (*)\n\n\n\n\nA vs C\n\n\n-0.165\n\n\n0.042\n\n\n-3.91\n\n\n0.0006 (***)\n\n\n\n\nA vs D\n\n\n-0.157\n\n\n0.043\n\n\n-3.67\n\n\n0.0014 (**)\n\n\n\n\nB vs C\n\n\n-0.031\n\n\n0.047\n\n\n-0.64\n\n\n0.918\n\n\n\n\nB vs D\n\n\n-0.023\n\n\n0.048\n\n\n-0.48\n\n\n0.964\n\n\n\n\nC vs D\n\n\n0.008\n\n\n0.043\n\n\n0.18\n\n\n0.998\n\n\n\n\n\n\n\nMobile Genetic Element (MGE)\n\n\n\nData: Shannon by pregnancy outcome groups (A-D) Part I. Family: binomial Number of observations: 1947, groups: PATIENT, 1547\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\nSignificance\n\n\n\n\n\n\n(Intercept)\n\n\n0.203\n\n\n0.104\n\n\n1.95\n\n\n0.051 (.)\n\n\n·\n\n\n\n\nGroup B\n\n\n-0.128\n\n\n0.167\n\n\n-0.77\n\n\n0.444\n\n\n\n\n\n\nGroup C\n\n\n0.437\n\n\n0.160\n\n\n2.74\n\n\n0.0062 (**)\n\n\n**\n\n\n\n\nGroup D\n\n\n0.513\n\n\n0.160\n\n\n3.21\n\n\n0.00135 (**)\n\n\n**\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nOdds ratio\n\n\nSE\n\n\nz value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n1.136\n\n\n0.190\n\n\n0.77\n\n\n0.8698\n\n\n\n\nA vs C\n\n\n0.646\n\n\n0.103\n\n\n-2.74\n\n\n0.0316 (*)\n\n\n\n\nA vs D\n\n\n0.599\n\n\n0.0958\n\n\n-3.21\n\n\n0.0074 (**)\n\n\n\n\nB vs C\n\n\n0.569\n\n\n0.102\n\n\n-3.14\n\n\n0.0091 (**)\n\n\n\n\nB vs D\n\n\n0.527\n\n\n0.0949\n\n\n-3.56\n\n\n0.0021 (**)\n\n\n\n\nC vs D\n\n\n0.927\n\n\n0.156\n\n\n-0.45\n\n\n0.969\n\n\n\n\n\nPart II. Family: gaussian Number of observations:1133, groups: PATIENT, 959 Dispersion estimate for gaussian family (sigma^2): 0.166\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nEstimate\n\n\nStd. Error\n\n\nz value\n\n\np-value\n\n\n\n\n\n\n(Intercept)\n\n\n1.031\n\n\n0.035\n\n\n29.21\n\n\n&lt; 2e-16 (***)\n\n\n\n\nGroup B\n\n\n0.0457\n\n\n0.0570\n\n\n0.80\n\n\n0.423\n\n\n\n\nGroup C\n\n\n0.119\n\n\n0.0514\n\n\n2.32\n\n\n0.020 (*)\n\n\n\n\nGroup D\n\n\n-0.0728\n\n\n0.0506\n\n\n-1.44\n\n\n0.150\n\n\n\n\n\nConfidence level: 0.95 p-value adjustment: Tukey method for comparing a family of 4 estimates.\n\n\n\n\n\n\n\n\n\n\n\n\nContrast\n\n\nEstimate\n\n\nSE\n\n\nt value\n\n\np-value\n\n\n\n\n\n\nA vs B\n\n\n-0.0457\n\n\n0.0570\n\n\n-0.80\n\n\n0.854\n\n\n\n\nA vs C\n\n\n-0.1193\n\n\n0.0514\n\n\n-2.32\n\n\n0.094\n\n\n\n\nA vs D\n\n\n0.0728\n\n\n0.0506\n\n\n1.44\n\n\n0.475\n\n\n\n\nB vs C\n\n\n-0.0736\n\n\n0.0584\n\n\n-1.26\n\n\n0.589\n\n\n\n\nB vs D\n\n\n0.1185\n\n\n0.0576\n\n\n2.06\n\n\n0.168\n\n\n\n\nC vs D\n\n\n0.1921\n\n\n0.0521\n\n\n3.69\n\n\n\n\n\n(**)\n\n\n\n\n\n\n\n\n\n\nGLMMs Diagnostics\n\n Model Diagnostic"
  },
  {
    "objectID": "Reports/R8.html",
    "href": "Reports/R8.html",
    "title": "\nβ-diversity comparison across pregnancy outcome groups\n",
    "section": "",
    "text": "Significance codes: *** p &lt; 0.001, ** p &lt; 0.01, * p &lt; 0.05, . p &lt; 0.1\n\n\nβ-diversity comparison across pregnancy outcome groups\n\n\nReport 8: PERMANOVA multivariate analysis of β-diversity across clinical groups (A-D) in inclusion (IN) and delivery (DR) samples.\n\n\nFormula: distances ~ outcome_group + antibiotic treatment during pregnancy + maternal age + body mass index (BMI) + cervical cerclage + intrauterine growth restriction (IUGR) + gestational diabetes + hypertensive disorders of pregnancy\n\n\n\nSpecies\n\n\n\nPermutation test for adonis under reduced model Marginal effects of terms Permutation: free Number of permutations: 999\n\n\nData: genes detected IN Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nClinical groups (A-D)\n\n\n3\n\n\n2.95\n\n\n0.00775\n\n\n2.7245\n\n\n0.001 ***\n\n\n\n\nAntibiotic (Yes)\n\n\n1\n\n\n1.49\n\n\n0.00391\n\n\n4.1235\n\n\n0.003 **\n\n\n\n\nMaternal age\n\n\n1\n\n\n0.78\n\n\n0.00206\n\n\n2.1685\n\n\n0.037 *\n\n\n\n\nBMI\n\n\n1\n\n\n3.18\n\n\n0.00837\n\n\n8.8276\n\n\n0.001 ***\n\n\n\n\nCervical cerclage (Yes)\n\n\n1\n\n\n0.76\n\n\n0.00201\n\n\n2.1190\n\n\n0.047 *\n\n\n\n\nIUGR (Yes)\n\n\n1\n\n\n0.50\n\n\n0.00132\n\n\n1.3943\n\n\n0.190\n\n\n\n\nGestational diabetes (Yes)\n\n\n1\n\n\n0.23\n\n\n0.00060\n\n\n0.6371\n\n\n0.703\n\n\n\n\nHypertensive disorders (Yes)\n\n\n1\n\n\n0.23\n\n\n0.00060\n\n\n0.6350\n\n\n0.715\n\n\n\n\nResidual\n\n\n1022\n\n\n368.64\n\n\n0.96888\n\n\n\n\n\n\n\n\nTotal\n\n\n1032\n\n\n380.48\n\n\n1.00000\n\n\n\n\n\n\n\n\n\nData: genes detected DR Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nClinical groups (A-D)\n\n\n3\n\n\n4.67\n\n\n0.01343\n\n\n4.1771\n\n\n0.001 ***\n\n\n\n\nAntibiotic (Yes)\n\n\n1\n\n\n0.46\n\n\n0.00133\n\n\n1.2456\n\n\n0.240\n\n\n\n\nMaternal age\n\n\n1\n\n\n0.65\n\n\n0.00186\n\n\n1.7359\n\n\n0.096\n\n\n\n\nBMI\n\n\n1\n\n\n3.62\n\n\n0.01040\n\n\n9.7059\n\n\n0.001 ***\n\n\n\n\nCervical cerclage (Yes)\n\n\n1\n\n\n1.00\n\n\n0.00287\n\n\n2.6761\n\n\n0.016 *\n\n\n\n\nIUGR (Yes)\n\n\n1\n\n\n0.34\n\n\n0.00098\n\n\n0.9122\n\n\n0.452\n\n\n\n\nGestational diabetes (Yes)\n\n\n1\n\n\n0.29\n\n\n0.00083\n\n\n0.7709\n\n\n0.587\n\n\n\n\nHypertensive disorders (Yes)\n\n\n1\n\n\n0.50\n\n\n0.00145\n\n\n1.3500\n\n\n0.194\n\n\n\n\nResidual\n\n\n899\n\n\n335.36\n\n\n0.96339\n\n\n\n\n\n\n\n\nTotal\n\n\n909\n\n\n348.10\n\n\n1.00000\n\n\n\n\n\n\n\n\n\n\n\nAntibiotic Resistance Genes (ARG)\n\n\n\nPermutation test for adonis under reduced model Permutation: free Number of permutations: 999 Marginal effects of terms\n\n\nData: genes detected IN Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nOUT_GROUP\n\n\n3\n\n\n1.576\n\n\n0.00814\n\n\n1.6627\n\n\n0.036 *\n\n\n\n\nBIL_INC_ATB\n\n\n1\n\n\n0.471\n\n\n0.00243\n\n\n1.4901\n\n\n0.145\n\n\n\n\nPAT_AGE\n\n\n1\n\n\n0.432\n\n\n0.00223\n\n\n1.3681\n\n\n0.183\n\n\n\n\nIMC\n\n\n1\n\n\n0.703\n\n\n0.00363\n\n\n2.2237\n\n\n0.030 *\n\n\n\n\nCERCLAGE\n\n\n1\n\n\n0.364\n\n\n0.00188\n\n\n1.1509\n\n\n0.305\n\n\n\n\nRCIU\n\n\n1\n\n\n0.302\n\n\n0.00156\n\n\n0.9550\n\n\n0.428\n\n\n\n\nDIABET_GESTA\n\n\n1\n\n\n0.356\n\n\n0.00184\n\n\n1.1279\n\n\n0.297\n\n\n\n\nHTA_PRE_ECLAM\n\n\n1\n\n\n0.443\n\n\n0.00229\n\n\n1.4005\n\n\n0.174\n\n\n\n\nResidual\n\n\n596\n\n\n188.310\n\n\n0.97280\n\n\n\n\n\n\n\n\nTotal\n\n\n606\n\n\n193.575\n\n\n1.00000\n\n\n\n\n\n\n\n\n\nData: genes detected DR Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nOUT_GROUP\n\n\n3\n\n\n1.786\n\n\n0.01133\n\n\n1.8383\n\n\n0.016 *\n\n\n\n\nBIL_INC_ATB\n\n\n1\n\n\n0.504\n\n\n0.00320\n\n\n1.5569\n\n\n0.118\n\n\n\n\nPAT_AGE\n\n\n1\n\n\n0.792\n\n\n0.00502\n\n\n2.4459\n\n\n0.021 *\n\n\n\n\nIMC\n\n\n1\n\n\n0.307\n\n\n0.00195\n\n\n0.9484\n\n\n0.439\n\n\n\n\nCERCLAGE\n\n\n1\n\n\n0.623\n\n\n0.00395\n\n\n1.9219\n\n\n0.060 .\n\n\n\n\nRCIU\n\n\n1\n\n\n0.366\n\n\n0.00232\n\n\n1.1291\n\n\n0.289\n\n\n\n\nDIABET_GESTA\n\n\n1\n\n\n0.203\n\n\n0.00129\n\n\n0.6257\n\n\n0.742\n\n\n\n\nHTA_PRE_ECLAM\n\n\n1\n\n\n0.234\n\n\n0.00148\n\n\n0.7219\n\n\n0.638\n\n\n\n\nResidual\n\n\n470\n\n\n152.248\n\n\n0.96548\n\n\n\n\n\n\n\n\nTotal\n\n\n480\n\n\n157.691\n\n\n1.00000\n\n\n\n\n\n\n\n\n\n\n\nMobile Genetic Element (MGE)\n\n\n\nPermutation test for adonis under reduced model Marginal effects of terms Permutation: free Number of permutations: 999\n\n\nData: genes detected IN Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nOUT_GROUP\n\n\n3\n\n\n1.935\n\n\n0.01019\n\n\n2.1400\n\n\n0.009 **\n\n\n\n\nBIL_INC_ATB\n\n\n1\n\n\n0.403\n\n\n0.00212\n\n\n1.3380\n\n\n0.209\n\n\n\n\nPAT_AGE\n\n\n1\n\n\n1.347\n\n\n0.00710\n\n\n4.4693\n\n\n0.002 **\n\n\n\n\nIMC\n\n\n1\n\n\n0.803\n\n\n0.00423\n\n\n2.6628\n\n\n0.026 *\n\n\n\n\nCERCLAGE\n\n\n1\n\n\n0.584\n\n\n0.00308\n\n\n1.9385\n\n\n0.105\n\n\n\n\nRCIU\n\n\n1\n\n\n0.141\n\n\n0.00075\n\n\n0.4693\n\n\n0.851\n\n\n\n\nDIABET_GESTA\n\n\n1\n\n\n0.344\n\n\n0.00181\n\n\n1.1421\n\n\n0.302\n\n\n\n\nHTA_PRE_ECLAM\n\n\n1\n\n\n0.438\n\n\n0.00231\n\n\n1.4542\n\n\n0.156\n\n\n\n\nResidual\n\n\n607\n\n\n182.938\n\n\n0.96389\n\n\n\n\n\n\n\n\nTotal\n\n\n617\n\n\n189.791\n\n\n1.00000\n\n\n\n\n\n\n\n\n\nData: genes detected DR Samples\n\n\n\n\n\n\n\n\n\n\n\n\n\nVariable\n\n\nDf\n\n\nSumOfSqs\n\n\nR2\n\n\nF\n\n\nPr(&gt;F)\n\n\n\n\n\n\nOUT_GROUP\n\n\n3\n\n\n2.917\n\n\n0.01861\n\n\n3.1861\n\n\n0.001 ***\n\n\n\n\nBIL_INC_ATB\n\n\n1\n\n\n0.365\n\n\n0.00233\n\n\n1.1958\n\n\n0.241\n\n\n\n\nPAT_AGE\n\n\n1\n\n\n0.168\n\n\n0.00107\n\n\n0.5491\n\n\n0.776\n\n\n\n\nIMC\n\n\n1\n\n\n0.547\n\n\n0.00349\n\n\n1.7935\n\n\n0.096 .\n\n\n\n\nCERCLAGE\n\n\n1\n\n\n0.155\n\n\n0.00099\n\n\n0.5085\n\n\n0.836\n\n\n\n\nRCIU\n\n\n1\n\n\n0.351\n\n\n0.00224\n\n\n1.1486\n\n\n0.271\n\n\n\n\nDIABET_GESTA\n\n\n1\n\n\n0.267\n\n\n0.00170\n\n\n0.8735\n\n\n0.447\n\n\n\n\nHTA_PRE_ECLAM\n\n\n1\n\n\n0.153\n\n\n0.00097\n\n\n0.5005\n\n\n0.843\n\n\n\n\nResidual\n\n\n494\n\n\n150.756\n\n\n0.96193\n\n\n\n\n\n\n\n\nTotal\n\n\n504\n\n\n156.723\n\n\n1.00000"
  },
  {
    "objectID": "Tables/T10T11T12T13T14.html",
    "href": "Tables/T10T11T12T13T14.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Table 10\n\n Download Table S10 (CSV) \n\nSupplementary Table 10: Differential abundance of species across clinical outcome groups.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = Abundance ~ “OUT_GROUP”+“BIL_INC_ATB”,“PAT_AGE”+ “IMC”+ “CERCLAGE”+“RCIU”+“DIABET_GESTA”+ “HTA_PRE_ECLAM”+(1|PatientID) OUT_GROUP: study outcome group(A-D); BIL_INC_ATB: antibiotic exposure during pregnancy; PAT_AGE: maternal age; IMC: body mass index; CERCLAGE: cervical cerclage; RCIU intrauterine growth restriction; DIABET_GESTA gestational diabetes; HTA_PRE_ECLAM: hypertensive disorders of pregnancy including pre-eclampsia. model = LMCLR\n\n\n\n\nSupplementary Table 11\n\n Download Table S11 (CSV) \n\n\nSupplementary Table 11: Differential abundance of Antibiotic Resistance Genes (ARGs) across clinical outcome groups.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = Abundance ~ “OUT_GROUP”+“BIL_INC_ATB”,“PAT_AGE”+ “IMC”+ “CERCLAGE”+“RCIU”+“DIABET_GESTA”+ “HTA_PRE_ECLAM”+(1|PatientID) OUT_GROUP: study outcome group(A-D); BIL_INC_ATB: antibiotic exposure during pregnancy; PAT_AGE: maternal age; IMC: body mass index; CERCLAGE: cervical cerclage; RCIU intrauterine growth restriction; DIABET_GESTA gestational diabetes; HTA_PRE_ECLAM: hypertensive disorders of pregnancy including pre-eclampsia. model = CPLM\n\n\n\n\nSupplementary Table 12\n\n Download Table S12 (CSV) \n\n\nSupplementary Table 12: Differential abundance of Antibiotic Resistance Genes (ARGs) grouped by antibiotic classes across clinical outcome groups.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = Abundance ~ “OUT_GROUP”+“BIL_INC_ATB”,“PAT_AGE”+ “IMC”+ “CERCLAGE”+“RCIU”+“DIABET_GESTA”+ “HTA_PRE_ECLAM”+(1|PatientID) OUT_GROUP: study outcome group(A-D); BIL_INC_ATB: antibiotic exposure during pregnancy; PAT_AGE: maternal age; IMC: body mass index; CERCLAGE: cervical cerclage; RCIU intrauterine growth restriction; DIABET_GESTA gestational diabetes; HTA_PRE_ECLAM: hypertensive disorders of pregnancy including pre-eclampsia. model = CPLM\n\n\n\n\nSupplementary Table 13\n\n Download Table S13 (CSV) \n\n\nSupplementary Table 13: Differential abundance of Mobile Genetic Elements (MGEs) across clinical outcome groups.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = Abundance ~ “OUT_GROUP”+“BIL_INC_ATB”,“PAT_AGE”+ “IMC”+ “CERCLAGE”+“RCIU”+“DIABET_GESTA”+ “HTA_PRE_ECLAM”+(1|PatientID) OUT_GROUP: study outcome group(A-D); BIL_INC_ATB: antibiotic exposure during pregnancy; PAT_AGE: maternal age; IMC: body mass index; CERCLAGE: cervical cerclage; RCIU intrauterine growth restriction; DIABET_GESTA gestational diabetes; HTA_PRE_ECLAM: hypertensive disorders of pregnancy including pre-eclampsia. model = CPLM\n\n\n\n\nSupplementary Table 14\n\n Download Table S14 (CSV) \n\n\nSupplementary Table 14: Differential abundance of Mobile Genetic Elements (MGEs) grouped by MGE family level across clinical outcome groups.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\nFormula = Abundance ~ “OUT_GROUP”+“BIL_INC_ATB”,“PAT_AGE”+ “IMC”+ “CERCLAGE”+“RCIU”+“DIABET_GESTA”+ “HTA_PRE_ECLAM”+(1|PatientID) OUT_GROUP: study outcome group(A-D); BIL_INC_ATB: antibiotic exposure during pregnancy; PAT_AGE: maternal age; IMC: body mass index; CERCLAGE: cervical cerclage; RCIU intrauterine growth restriction; DIABET_GESTA gestational diabetes; HTA_PRE_ECLAM: hypertensive disorders of pregnancy including pre-eclampsia. model = CPLM"
  },
  {
    "objectID": "Tables/T2T6T7.html",
    "href": "Tables/T2T6T7.html",
    "title": "VagResist",
    "section": "",
    "text": "Supplementary Table 2\n\n Download Table S2 (CSV) \n\nSupplementary Table 2: Species-ARGs read count table.\n\n\n\n\n    \n    \n    \n        \n        \n        \n        \n        \n        \n        \n        \n    \n    \n   \n    \n      \n  \n        \n    \n    \n  \n        \n    \n    \n  \n        \n    \n      \n  \n        \n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n\n            \n                \n                \n            \n        \n    \n\n\n    Loading ITables v2.6.2 from the internet...\n    (need help?)\n    \n\n\n\n\n\n\n\n\nSupplementary Table 6\n\n\n\nSupplementary Table 6: SparCC correlation matrix beetween species and Antibiotic Resistance Genes (ARGs).\ncorrelation matrix computed using the top 20 most abundant species and 50 ARGs.   Download Table S6 (xlsx) \n\n\n\n\nSupplementary Table 7\n\n\n\nSupplementary Table 7: SparCC correlation matrix beetween species, Antibiotic Resistance Genes (ARGs) and Mobile Genetic Element (MGEs).\ncorrelation matrix computed using the top 20 most abundant species, 50 ARGs and 50 MGEs.\n Download Table S7 (xlsx)"
  }
]